IL31870A - Steroid esters of the pregnane series and process of preparation - Google Patents
Steroid esters of the pregnane series and process of preparationInfo
- Publication number
- IL31870A IL31870A IL31870A IL3187069A IL31870A IL 31870 A IL31870 A IL 31870A IL 31870 A IL31870 A IL 31870A IL 3187069 A IL3187069 A IL 3187069A IL 31870 A IL31870 A IL 31870A
- Authority
- IL
- Israel
- Prior art keywords
- ethoxyethyl
- compound according
- ethoxy
- hydroxyl radical
- dioxo
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- -1 Steroid esters Chemical class 0.000 title description 8
- 150000003128 pregnanes Chemical class 0.000 title description 4
- 238000002360 preparation method Methods 0.000 title description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 10
- 229960003957 dexamethasone Drugs 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000008263 liquid aerosol Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000008275 solid aerosol Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000286 vaginal jelly Substances 0.000 description 2
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- BAKGFNOISJEFPX-UHFFFAOYSA-N 2-ethoxyethyl carbonochloridate Chemical compound CCOCCOC(Cl)=O BAKGFNOISJEFPX-UHFFFAOYSA-N 0.000 description 1
- 241001237754 Algia Species 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 241000786363 Rhampholeon spectrum Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 241001342522 Vampyrum spectrum Species 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
- F16B39/00—Locking of screws, bolts or nuts
- F16B39/02—Locking of screws, bolts or nuts in which the locking takes place after screwing down
- F16B39/04—Locking of screws, bolts or nuts in which the locking takes place after screwing down with a member penetrating the screw-threaded surface of at least one part, e.g. a pin, a wedge, cotter-pin, screw
- F16B39/06—Locking of screws, bolts or nuts in which the locking takes place after screwing down with a member penetrating the screw-threaded surface of at least one part, e.g. a pin, a wedge, cotter-pin, screw with a pin or staple parallel to the bolt axis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR148895A FR7604M (enExample) | 1968-04-22 | 1968-04-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL31870A0 IL31870A0 (en) | 1969-05-28 |
| IL31870A true IL31870A (en) | 1972-10-29 |
Family
ID=8649224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL31870A IL31870A (en) | 1968-04-22 | 1969-03-21 | Steroid esters of the pregnane series and process of preparation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3591612A (enExample) |
| AT (1) | AT285836B (enExample) |
| BE (1) | BE731782A (enExample) |
| CH (1) | CH506508A (enExample) |
| DK (1) | DK127976B (enExample) |
| ES (1) | ES366287A1 (enExample) |
| FR (1) | FR7604M (enExample) |
| GB (1) | GB1208230A (enExample) |
| IL (1) | IL31870A (enExample) |
| NL (1) | NL6905568A (enExample) |
| SE (1) | SE350255B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011003870A2 (en) * | 2009-07-06 | 2011-01-13 | Creabilis S.A. | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
| US11612567B2 (en) | 2018-02-02 | 2023-03-28 | Ripple Therapeutics Corporation | Ocular inserts comprising a covalently linked steroid dimer |
| WO2020154815A1 (en) * | 2019-02-01 | 2020-08-06 | Ripple Therapeutics Corporation | Crystalline forms of dexamethasone dimers and uses thereof |
| EP4146664A4 (en) | 2020-05-01 | 2024-11-13 | Ripple Therapeutics Corporation | HETERODIMER COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES |
-
1968
- 1968-04-22 FR FR148895A patent/FR7604M/fr not_active Expired
-
1969
- 1969-03-21 IL IL31870A patent/IL31870A/en unknown
- 1969-04-10 NL NL6905568A patent/NL6905568A/xx unknown
- 1969-04-11 CH CH556069A patent/CH506508A/fr not_active IP Right Cessation
- 1969-04-15 US US816386A patent/US3591612A/en not_active Expired - Lifetime
- 1969-04-21 ES ES366287A patent/ES366287A1/es not_active Expired
- 1969-04-21 BE BE731782D patent/BE731782A/xx unknown
- 1969-04-21 SE SE05626/69A patent/SE350255B/xx unknown
- 1969-04-22 DK DK218669AA patent/DK127976B/da unknown
- 1969-04-22 AT AT389269A patent/AT285836B/de not_active IP Right Cessation
- 1969-04-22 GB GB20400/69A patent/GB1208230A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH506508A (fr) | 1971-04-30 |
| AT285836B (de) | 1970-11-10 |
| IL31870A0 (en) | 1969-05-28 |
| DE1919811B2 (de) | 1974-02-21 |
| BE731782A (enExample) | 1969-10-21 |
| ES366287A1 (es) | 1971-02-16 |
| US3591612A (en) | 1971-07-06 |
| FR7604M (enExample) | 1970-01-19 |
| NL6905568A (enExample) | 1969-10-24 |
| DE1919811A1 (de) | 1969-10-23 |
| SE350255B (enExample) | 1972-10-23 |
| DK127976B (da) | 1974-02-11 |
| GB1208230A (en) | 1970-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3318926A (en) | 7alpha-methyl-16alpha-hydroxy-estrones | |
| ATWATER et al. | Steroidal Aldosterone Antagonists. IV1 | |
| US4076737A (en) | Aldehydes of the pregnane series and derivatives thereof | |
| IL31870A (en) | Steroid esters of the pregnane series and process of preparation | |
| Taub et al. | Selective Sodium Borohydride Reductions in Aqueous Dimethylformamide Solution. Neighboring Group Effects in the Cortical Side Chain1 | |
| US3381003A (en) | 3-keto-13beta-alkyl-17beta-acetyl-gona-4-ene-17alpha-ol compounds and processes of preparing them | |
| US3328432A (en) | Novel progesterone derivatives | |
| US2656349A (en) | 14,15-oxides of the cyclopentanopolyhydrophenanthrene and polyhydrochrysene series | |
| US3492338A (en) | D-homosteroids and process for their preparation | |
| Sargent et al. | Hydroxylated codeine derivatives | |
| US3856829A (en) | 16{62 -hydrocarbon substituted estrane compounds | |
| US3080360A (en) | 17alpha-alkyl-17beta-hydroxy-18-norandrost-4-en-3-ones | |
| US3030391A (en) | 12-alkoxy-11-oxygenated pregnanes | |
| US3493563A (en) | Process for the production of intermediates for triamcinolone and related compounds | |
| JPS5839840B2 (ja) | プレグナン誘導体の製造方法 | |
| Rosenkranz et al. | Steroids. LX. 1 Synthesis of C-2 Oxygenated Derivatives of Reichstein's Substance S and of Cortisone | |
| US3207767A (en) | 19-alkyl androstanes | |
| US3414565A (en) | 3, 5-cyclo-6beta, 19-oxido steroids and processes for their preparation | |
| US4011317A (en) | Steroid derivatives | |
| US3457258A (en) | 5h-1,4-benzodiazepin-5-ones and-5-thiones | |
| US3598811A (en) | Derivatives of 4alpha,8,14-trimethyl-18-nor-5alpha,8alpha,9beta,13alpha,14beta,17alpha-pregnane | |
| US3519654A (en) | 13beta-lower alkyl-delta**4,9-gonadiene-3-ones | |
| NO138147B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 15alfa,16alfa-methylen-4-pregnener | |
| US3391140A (en) | 13-lower alkyl-gona-delta5(10)8(14)-dien-3-on-17beta-ol and process for the preparatin thereof | |
| US2862935A (en) | 3, 5-dienic-7-oxopregnane derivatives and processes |